July 26, 2021
1 min watch
Save
VIDEO: Holland discusses Eysuvis for dry eye
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this Healio Video Perspective from Eyecelerator@ASCRS, Edward J. Holland, MD, discusses Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%, Kala Pharmaceuticals) and its utility for patients with dry eye disease.